Here Are All The Big Biotech Mergers In 2016


Biotech is one of the sectors where M&A activities never stop, as the potential for growth and development is immense. After the termination of a $160 billion merger with Allergan plc Ordinary Shares , Pfizer Inc. has returned to the M&A table with a bang.



from Biotech News